Cross Country Healthcare buy Barrington Research
Start price
27.02.24
/
50%
€16.90
Target price
27.02.25
€22.11
Performance (%)
-2.96%
End price
28.02.25
€16.40
Summary
This prediction ended on 28.02.25 with a price of €16.40. With a performance of -2.96%, the BUY prediction by Barrington_Research finished with a loss. Barrington_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cross Country Healthcare | -1.796% | -1.796% | -34.921% |
| iShares Core DAX® | 4,24 % | 2,86 % | 14,03 % |
| iShares Nasdaq 100 | 4,89 % | 2,81 % | 32,71 % |
| iShares Nikkei 225® | 9,40 % | 7,83 % | 48,30 % |
| iShares S&P 500 | 3,53 % | 1,95 % | 25,25 % |
Comments by Barrington_Research for this prediction
In the thread Cross Country Healthcare diskutieren
Cross Country Healthcare, Inc. (NASDAQ: CCRN) had its price target lowered by analysts at Barrington Research from $26.00 to $24.00. They now have an "outperform" rating on the stock.
Ratings data for CCRN provided by MarketBeat
In the thread Trading Cross Country Healthcare
Die von Barrington_Research gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Barrington_Research for Cross Country Healthcare
Cross Country Healthcare
Start price
Target price
Perf. (%)
€13.90
08.08.24
08.08.24
€17.41
08.08.25
08.08.25
-22.30%
09.08.25
09.08.25
Cross Country Healthcare
Start price
Target price
Perf. (%)
€15.40
06.05.24
06.05.24
€19.47
06.05.25
06.05.25
-20.78%
07.05.25
07.05.25
Cross Country Healthcare
Start price
Target price
Perf. (%)
€18.50
29.11.23
29.11.23
€23.68
29.11.24
29.11.24
-41.62%
30.11.24
30.11.24